Developing new vaccines and therapeutic antibodies
Vaccines and Therapeutics Technology Core
This study is working on new and quicker ways to make vaccines and treatments for infections, using cutting-edge technology, so that patients can have access to better options for their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10863657 on NIH RePORTER |
What this research studies
This research focuses on creating a fast-track process for developing next-generation vaccines and therapeutic antibodies. It involves producing various candidate molecules using advanced technologies, including recombinant virus-like particles and RNA lipid nanoparticles. The project aims to provide essential resources and quality control to ensure the effectiveness of these candidates. Patients may benefit from innovative treatments for infectious diseases as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk for infectious diseases or those who may require new therapeutic options.
Not a fit: Patients with conditions unrelated to infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and therapies for infectious diseases.
How similar studies have performed: Previous research has shown success in developing vaccines and therapeutic antibodies using similar advanced technologies.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Carnahan, Robert H — Vanderbilt University Medical Center
- Study coordinator: Carnahan, Robert H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.